Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Graziano

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
Cancer Research|October 27, 1997
Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cellsT Keler, R F Graziano, A Mandal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic miceT Keler, P M Guyre, L A Vitale, et al.
BMC Cancer|August 24, 2001
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancerF Graziano, S Cascinu, M P Staccioli, et al.
Anticancer Research|March 28, 2001
Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapyS Cascinu, F Graziano, V Catalano, et al.
Journal of Endocrinological Investigation|February 5, 2004
Localization and expression of thyroid hormone receptors normal and neoplastic human thyroidA Crescenzi, M F Graziano, E Carosa, et al.
British Journal of Cancer|March 17, 2005
Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patientsM Scartozzi, E Galizia, F Graziano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1997
Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cellsN A Fanger, D Voigtlaender, C Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaquesTibor Keler, Ed Halk, Laura Vitale, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Human alveolar macrophage FcR-mediated cytotoxicity. Heteroantibody- versus conventional antibody-mediated target cell lysisP C Levy, R J Looney, L Shen, et al.
Oncology|July 15, 2005
The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patientsM Scartozzi, A Sobrero, G Gasparini, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
Cancer Research|October 27, 1997
Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cellsT Keler, R F Graziano, A Mandal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000
Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic miceT Keler, P M Guyre, L A Vitale, et al.
BMC Cancer|August 24, 2001
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancerF Graziano, S Cascinu, M P Staccioli, et al.
Anticancer Research|March 28, 2001
Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapyS Cascinu, F Graziano, V Catalano, et al.
Journal of Endocrinological Investigation|February 5, 2004
Localization and expression of thyroid hormone receptors normal and neoplastic human thyroidA Crescenzi, M F Graziano, E Carosa, et al.
British Journal of Cancer|March 17, 2005
Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patientsM Scartozzi, E Galizia, F Graziano, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1997
Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cellsN A Fanger, D Voigtlaender, C Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaquesTibor Keler, Ed Halk, Laura Vitale, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1990
Human alveolar macrophage FcR-mediated cytotoxicity. Heteroantibody- versus conventional antibody-mediated target cell lysisP C Levy, R J Looney, L Shen, et al.
Oncology|July 15, 2005
The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patientsM Scartozzi, A Sobrero, G Gasparini, et al.
Pageof 17